Spin-Off of Theravance Biopharma, Inc. (Details) $ in Thousands	Jun. 02, 2014 USD ($)	Jun. 01, 2014 USD ($)
Spin-Off of Theravance Biopharma, Inc.
Cash, cash equivalents and marketable securities		$ 393,000
Number of shares of Theravance Biopharma issued for every share of Theravance	0.286
Theravance Biopharma | Discontinued operation
Allocation of net book value of assets transferred pursuant to spin-off
Cash and cash equivalents	$ 277,541
Marketable investment securities	115,129
Accounts receivable	125
Reimbursement of certain liabilities	16,983
Prepaid and other current assets	3,172
Inventories	14,328
Fixed assets, net	9,580
Accrued liabilities	(22,342)
Deferred revenue	(6,694)
Other liabilities	(4,944)
Net book value of assets contributed	$ 402,878